Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Surgery Partners, Inc. (SGRY) shares are reported as beneficially owned by Glenview Capital Management, LLC and Larry Robbins, Glenview Capital Management’s Chief Investment Officer, each of whom may be deemed the beneficial owner of 7,023,338 shares, approximately 5.4% of the common stock. Each reported shared voting and dispositive power over 7,023,338 shares, with zero sole voting or dispositive power. The shares consist of 1,505,330 held for Glenview Capital Master Fund, 2,846,687 for Glenview Offshore Opportunity Master Fund, 339,115 for Glenview Healthcare Master Fund, and an aggregate 2,332,206 for two separately managed accounts. Surgery Partners had 130,918,260 shares outstanding as of August 3, 2026.
Key Figures
Beneficial ownership:7,023,338 sharesPercent of class:Approximately 5.4%Shares outstanding:130,918,260 shares+4 more
7 metrics
Beneficial ownership7,023,338 sharesEach reporting person may be deemed the beneficial owner
Percent of classApproximately 5.4%Each reporting person's reported beneficial ownership
Shares outstanding130,918,260 sharesAs of August 3, 2026
Glenview Capital Master Fund shares1,505,330 sharesHeld for the account of Glenview Capital Master Fund
Glenview Offshore Opportunity Master Fund shares2,846,687 sharesHeld for the account of Glenview Offshore Opportunity Master Fund
Glenview Healthcare Master Fund shares339,115 sharesHeld for the account of Glenview Healthcare Master Fund
Managed Accounts shares2,332,206 sharesAggregate held for two separately managed accounts
"may be deemed the beneficial owner of 7,023,338 Shares"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
shared voting powerfinancial
"shared power to vote or to direct the vote"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive powerfinancial
"shared power to dispose or to direct the disposition"
Managed Accountsfinancial
"two separately managed accounts (the "Managed Accounts")"
Managed accounts are collections of investments owned by an individual or institution but run day-to-day by a professional who buys, sells and allocates assets according to an agreed plan. They matter to investors because they provide tailored oversight, active risk control and potential tax efficiency—like hiring a personal chef to manage your diet—while fees and the manager’s skill directly affect returns.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many SGRY shares do Glenview Capital Management and Larry Robbins report beneficially owning?
Glenview Capital Management, LLC and Larry Robbins each may be deemed beneficial owners of 7,023,338 SGRY common shares, approximately 5.4% of the class. The reported percentage uses 130,918,260 shares outstanding as of August 3, 2026.
Who has voting and dispositive power over SGRY shares?
Each reporting person reported shared voting power and shared dispositive power over 7,023,338 shares, and zero sole voting or dispositive power.
Which accounts hold the reported SGRY shares?
The reported shares include 1,505,330 held for Glenview Capital Master Fund, 2,846,687 for Glenview Offshore Opportunity Master Fund, and 339,115 for Glenview Healthcare Master Fund. An aggregate 2,332,206 shares were held for two separately managed accounts.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Surgery Partners, Inc.
(Name of Issuer)
Common Stock, par value $0.01 per share
(Title of Class of Securities)
86881A100
(CUSIP Number)
10/06/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
86881A100
1
Names of Reporting Persons
GLENVIEW CAPITAL MANAGEMENT, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
7,023,338.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
7,023,338.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
7,023,338.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.4 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
86881A100
1
Names of Reporting Persons
ROBBINS LARRY
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
7,023,338.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
7,023,338.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
7,023,338.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.4 %
12
Type of Reporting Person (See Instructions)
IN, HC
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Surgery Partners, Inc.
(b)
Address of issuer's principal executive offices:
340 Seven Springs Way, Suite 600, Brentwood, Tennessee 37027
Item 2.
(a)
Name of person filing:
This Statement is filed on behalf of each of the following persons (collectively, the "Reporting Persons"):
i. Glenview Capital Management, LLC ("Glenview Capital Management"); and
ii. Larry Robbins ("Mr. Robbins").
This Statement relates to shares of Common Stock, par value $0.01 per share ("Shares") held for the accounts of Glenview Capital Master Fund, Ltd., a Cayman Islands exempted company ("Glenview Capital Master Fund"), Glenview Offshore Opportunity Master Fund, Ltd., a Cayman Islands exempted company ("Glenview Offshore Opportunity Master Fund"), Glenview Healthcare Master Fund, L.P., a Cayman Islands limited partnership ("Glenview Healthcare Master Fund"), and two separately managed accounts (the "Managed Accounts").
Glenview Capital Management serves as investment manager to each of Glenview Capital Master Fund, Glenview Offshore Opportunity Master Fund, Glenview Healthcare Master Fund, and the Managed Accounts. Mr. Robbins is the Chief Investment Officer of Glenview Capital Management.
(b)
Address or principal business office or, if none, residence:
The address of the principal business office of each of the Reporting Persons is 520 Madison Avenue, 33rd Floor, New York, New York 10022.
(c)
Citizenship:
i. Glenview Capital Management is a Delaware limited liability company; and
ii. Mr. Robbins is a citizen of the United States of America.
(d)
Title of class of securities:
Common Stock, par value $0.01 per share
(e)
CUSIP Number(s):
86881A100
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
As of the date hereof, each of the Reporting Persons may be deemed the beneficial owner of 7,023,338 Shares. This amount consists of (A) 1,505,330 Shares held for the account of Glenview Capital Master Fund, (B) 2,846,687 Shares held for the account of Glenview Offshore Opportunity Master Fund, (C) 339,115 Shares held for the account of Glenview Healthcare Master Fund, and (D) an aggregate 2,332,206 Shares held for the Managed Accounts.
(b)
Percent of class:
As of the date hereof, each of the Reporting Persons may be deemed the beneficial owner of approximately 5.4% of the Shares outstanding. (There were 130,918,260 Shares outstanding as of August 3, 2026, based on the Issuer's quarterly report on Form 10-Q filed on August 10, 2026.)
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
7,023,338
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
7,023,338
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
See disclosure in Items 2 and 4 hereof. Certain funds listed in Item 2(a) are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares covered by this Statement that may be deemed to be beneficially owned by the Reporting Persons.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See disclosure in Item 2 hereof.
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
GLENVIEW CAPITAL MANAGEMENT, LLC
Signature:
/s/ Mark J. Horowitz
Name/Title:
Mark J. Horowitz, President
Date:
10/13/2026
ROBBINS LARRY
Signature:
/s/ Mark J. Horowitz
Name/Title:
Mark J. Horowitz, attorney-in-fact for Larry Robbins
Date:
10/13/2026
Exhibit Information
Exhibit 1: Joint Filing Agreement
Exhibit 2: Power of Attorney
